NEW YORK (GenomeWeb News) – A UK biomedical ethics group has started a consultation program with stakeholders in biomedical business and research to gather information on perceptions of personalized healthcare technologies, including DNA testing, body imaging, and telemedicine.

The Nuffield Council on Bioethics said on Tuesday that it will accept comments over the next three months as part of an effort to explore whether DNA testing and biomedical imaging technologies should be regulated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times' George Johnson muses on cancer's roots in multicellularity.

The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.

Jun Wang, the chief executive of BGI, has stepped down.

In PLOS this week: locus linked to non-syndromic hearing loss, phylogenetic relationships of Klebsiella pneumoniae isolates, and more.